A comparison study of leukotriene receptor antagonist plus topical nasal steroid versus oral antihistamine + topical nasal steroid versus leukotriene receptor antagonist + oral antihistamine + topical nasal in the treatment of perennial allergic rhinitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN02329306

Enrollment

Registered

2003-09-12

Start date

2002-07-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory: Allergic rhinitis Respiratory Perennial allergic rhinitis

Interventions

Patients are randomised into one of three groups: Group 1: leukotriene receptor antagonist plus topical nasal steroid Group 2: oral antihistamine plus topical nasal steroid Group three: leukotriene re

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 60 patients (20 in each group), patients seen in out-patients with symptoms, signs and test results consistent with perennial allergic rhinitis will be placed on a six-week course of topical nasal steroid spray.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Symptom scores at 12 week assessment	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026